SCHEMBL5778478

SCHEMBL5778478

O=C(ON1C(=O)CCC1=O)c1ccc(-c2ccccn2)nc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P4HTM Q9NXG6 4/20 0.52
HPGDS O60760 2/20 0.45
KDM4E B2RXH2 6/20 0.40
ALOX15 P16050 2/20 0.40
HPGD P15428 2/20 0.40
RAB9A P51151 2/20 0.40
LMNA P02545 2/20 0.40
HTT P42858 2/20 0.40
NPC1 O15118 1/20 0.40
ALDH1A1 P00352 1/20 0.40
TP53 P04637 1/20 0.40
PKM P14618 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HSD17B10 Q99714 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
KDM6B O15054 1/20 0.38
KDM4A O75164 1/20 0.38
KDM5C P41229 1/20 0.38
KDM4C Q9H3R0 1/20 0.38
KDM2A Q9Y2K7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL992708 0.79 KMT2A (0.56) P4HTMKDM4ERAB9ALMNANPC1
SCHEMBL2504660 0.77 ALDH1A1 (0.54) KDM4ELMNAALDH1A1L3MBTL1KMT2A
SCHEMBL133554 0.76 KMT2A (0.53) RAB9ALMNANPC1ALDH1A1TP53
SCHEMBL19309377 0.76 KMT2A (0.53) RAB9ALMNANPC1ALDH1A1TP53
SCHEMBL16938414 0.76 GABRP (0.49) KDM4EHPGDRAB9ANPC1ALDH1A1
SCHEMBL27076571 0.76 MAPK1 (0.38) KDM4ERAB9ANPC1L3MBTL1KMT2A
SCHEMBL4758814 0.76 HDAC1 (0.45) KDM4ERAB9ANPC1ALDH1A1L3MBTL1
SCHEMBL15498446 0.76 P4HTM (0.62) P4HTMHPGDSKDM4EALOX15RAB9A
SCHEMBL3688798 0.75 HRH3 (0.50) HPGDSHTTSMN1; SMN2
SCHEMBL1509187 0.75 MAPK1 (0.41) KDM4ERAB9ANPC1L3MBTL1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1644372-A2 SUBSTITUTED QUINOLIN-4-YLAMINE ANALOGUES NEUROGEN CORPORATION (US) 2006-04-12 EP disclosed
WO-2005007652-A2 SUBSTITUTED QUINOLIN-4-YLAMINE ANALOGUES NEUROGEN CORPORATION (US) 2005-01-27 WO disclosed